From: Visualizing adverse events in clinical trials using correspondence analysis with R-package visae
AE Class | Treatment | Average | |||
---|---|---|---|---|---|
5-FU | 5-FU + Oxa | Cape | Cape + Oxa | ||
G1 | 1.22 | 2.75 | 1.23 | 3.96 | 2.29 |
G2 | 60.67 | 74.01 | 63.08 | 70.73 | 67.12 |
G3 | 25.31 | 38.53 | 27.39 | 39.94 | 32.79 |
G4 | 0.61 | 3.06 | 2.15 | 4.27 | 2.52 |
G5 | 0.31 | 0.31 | 1.23 | 1.52 | 0.84 |